sci天天读
肿瘤突变负荷：临床实用性、挑战和新出现的改进
SCI9 September 2024Tumour mutational burden: clinical utility
小细胞肺癌的概述：亚型、弱点及可塑性的新进展综述
SCI9 September 2024Small cell lung cancer profiling: an upda...
肿瘤微环境细胞组成的遗传效应图谱
SCI8 September 2024An atlas of genetic effects on cellular c...
用于精准医学的临床和遗传数据共享框架
SCI7 September 2024A framework for sharing of clinical and g...
ZBTB46协调血管生成和免疫以控制肿瘤结果
SCI6 September 2024ZBTB46 coordinates angiogenesis and immun...
RAS的滴定改变衰老状态并影响肿瘤的发生
SCI5 September 2024Titration of RAS alters senescent state a...
肺腺癌的 N6-甲基腺苷表位转录组学研究
SCI4 September 2024The N6-methyladenosine Epitranscriptomic...
基于FDG-PET肿瘤残余摄取III 期非小细胞肺癌患者的适应性放疗或标准放疗：一项多中心随机对照2期试验
SCI3 September 2024Adaptive radiotherapy (up to 74 Gy) or st...
局部递送靶向细胞表面的免疫细胞因子可引发全身抗肿瘤免疫反应
SCI2 September 2024Local delivery of cell surface-targeted i...
糖鞘脂合成介导KRAS驱动癌症中的免疫逃逸
SCI1 September 2024Glycosphingolipid synthesis mediates immu...
癌症中的环状RNA
SCI31 August 2024Circular RNA in cancer（Nature Reviews Cancer
抗癌免疫中的三级淋巴结构
SCI30 August 2024Tertiary lymphoid structures in anticancer immunity
致癌KRAS依赖基质白细胞介素-33引导胰腺微环境促进肿瘤生长
SCI29 August 2024Oncogenic KRAS-Dependent Stromal Interleuki...
靶向p97-Npl4相互作用抑制肿瘤Treg细胞发育以增强肿瘤免疫
SCI28 August 2024Targeting p97-Npl4 interaction inhibits tum...
曲妥珠单抗- Deruxtecan治疗通过血浆游离DNA检测发现的人表皮生长因子受体2扩增的晚期实体瘤
SCI27 August 2024Trastuzumab Deruxtecan in Advanced Solid Tu...
KRAS G12C抑制剂IBI351单药治疗晚期非小细胞肺癌癌症患者的疗效和安全性：2期关键研究结果
SCI26 August 2024Efficacy and safety of KRAS G12C inhibitor...
Lung-MAP研究二代测序分析晚期肺鳞癌（SWOG S1400）
SCI25 August 2024Lung-MAP Next Generation Sequencing Analysi...
中国健康工作预期寿命的决定因素和不平等性
SCI24 August 2024Determinants and inequities in healthy work...
Lazertinib用于已接受过EGFR TKI治疗且CNS治疗失败的EGFR变异型非小细胞肺癌非随机对照试验
SCI22 August 2024Lazertinib in EGFR-Variant Non–Small Cell L...
酪氨酸激酶抑制剂联合或不联合立体定向放射外科（SRS）治疗EGFR和ALK驱动型的NSCLC脑转移（TURBO-NSCLC）
SCI21 August 2024Tyrosine Kinase Inhibitors With and Without...